SCYNEXIS, Inc. (SCYX) is a publicly traded Healthcare sector company. As of July 26, 2026, SCYX trades at $3.73 with a market cap of $37.04M and a P/E ratio of -7.77. SCYX moved -3.28% today. Year to date, SCYX is -26.27%; over the trailing twelve months it is -36.82%. Its 52-week range spans $3.68 to $11.92. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces SCYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover SCYX: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $17.50.
| Metric | Value |
|---|---|
| Price | $3.73 |
| Market Cap | $37.04M |
| P/E Ratio | -7.77 |
| EPS | $-0.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.92 |
| 52-Week Low | $3.68 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $20.34M |
| Net Income | $-24.52M |
| Gross Margin | 0.00% |
2 analysts cover SCYX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.